Companies Dominating the Pharmaceutical Microbiology Landscape
- NEOGEN Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hardy Diagnostics
- IDEXX
- Charles River Laboratories
- BioMerieux SA
- Merck KGAA
- Rapid Micro Biosystems.
- Abbott Laboratories, Inc
- Bio-Rad Laboratories
- Gen-Probe, Inc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of pharmaceutical microbiology is estimated at USD 7.06 billion.
The pharmaceutical microbiology market size was over USD 6.55 billion in 2024 and is anticipated to cross USD 20.32 billion by 2037, growing at more than 9.1% CAGR during the forecast period i.e., between 2025-2037. Growing investment in the healthcare infrastructure, rising demand for sterility of the products, and growing technological advancements will drive the market growth.
North America industry is estimated to hold largest revenue share of 36% by 2037, due to growing innovation in testing technologies in the region.
The major players in the market are NEOGEN Corporation, Hardy Diagnostics, IDEXX, Charles River Laboratories, BioMerieux SA, Merck KGAA, Rapid Micro Biosystems., Abbott Laboratories, Inc., Bio-Rad Laboratories, Gen-Probe, Inc., and others.
